Skip to main content
. 2015 May 2;13:139. doi: 10.1186/s12967-015-0473-5

Figure 1.

Figure 1

Schedule of treatment regimen and blood samples for safety and efficacy endpoints evaluation. T: time point expressed as days or months (m). Pre: pre-treatment time point.